Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.

Totiger TM, Srinivasan S, Jala VR, Lamichhane P, Dosch AR, Gaidarski AA 3rd, Joshi C, Rangappa S, Castellanos J, Vemula PK, Chen X, Kwon D, Kashikar N, VanSaun M, Merchant NB, Nagathihalli NS.

Mol Cancer Ther. 2019 Feb;18(2):301-311. doi: 10.1158/1535-7163.MCT-18-0464. Epub 2018 Nov 7.

PMID:
30404927
2.

Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium.

Kerlakian S, Dhar VK, Abbott DE, Kooby DA, Merchant NB, Kim HJ, Martin RC, Scoggins CR, Bentrem DJ, Weber SM, Maithel SK, Ahmad SA, Patel SH.

HPB (Oxford). 2018 Oct 23. pii: S1365-182X(18)34468-X. doi: 10.1016/j.hpb.2018.09.018. [Epub ahead of print]

PMID:
30361110
3.

Tobacco Carcinogen-Induced Production of GM-CSF Activates CREB to Promote Pancreatic Cancer.

Srinivasan S, Totiger T, Shi C, Castellanos J, Lamichhane P, Dosch AR, Messaggio F, Kashikar N, Honnenahally K, Ban Y, Merchant NB, VanSaun M, Nagathihalli NS.

Cancer Res. 2018 Nov 1;78(21):6146-6158. doi: 10.1158/0008-5472.CAN-18-0579. Epub 2018 Sep 19.

PMID:
30232221
4.

Long-term Quality of Life and Gastrointestinal Functional Outcomes After Pancreaticoduodenectomy.

Allen CJ, Yakoub D, Macedo FI, Dosch AR, Brosch J, Dudeja V, Ayala R, Merchant NB.

Ann Surg. 2018 Oct;268(4):657-664. doi: 10.1097/SLA.0000000000002962.

PMID:
30199443
5.

Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.

Nagathihalli NS, Castellanos JA, Lamichhane P, Messaggio F, Shi C, Dai X, Rai P, Chen X, VanSaun MN, Merchant NB.

Cancer Res. 2018 Nov 1;78(21):6235-6246. doi: 10.1158/0008-5472.CAN-18-0634. Epub 2018 Aug 28.

PMID:
30154150
6.

Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?: A Multi-institutional Study.

Dhar VK, Merchant NB, Patel SH, Edwards MJ, Wima K, Imbus J, Abbott DE, Weber SM, Louie R, Kim HJ, Martin RCG, Scoggins CR, Bentrem DJ, LeCompte MT, Idrees K, Lopez-Aguiar AG, Maithel SK, Kooby DA, Franco DA, Yakoub D, Ahmad SA.

Ann Surg. 2018 Sep;268(3):469-478. doi: 10.1097/SLA.0000000000002923.

PMID:
30063495
7.

Fine-Needle Aspiration-Based Grading of Pancreatic Neuroendocrine Neoplasms Using Ki-67: Is Accurate WHO Grading Possible on Cytologic Material?

Weiss VL, Kiernan C, Wright J, Merchant NB, Coogan AC, Shi C.

J Am Soc Cytopathol. 2018 May-Jun;7(3):154-459. doi: 10.1016/j.jasc.2018.02.001. Epub 2018 Feb 13.

PMID:
30038894
8.

NFκB in Pancreatic Stellate Cells Reduces Infiltration of Tumors by Cytotoxic T Cells and Killing of Cancer Cells, via Up-regulation of CXCL12.

Garg B, Giri B, Modi S, Sethi V, Castro I, Umland O, Ban Y, Lavania S, Dawra R, Banerjee S, Vickers S, Merchant NB, Chen SX, Gilboa E, Ramakrishnan S, Saluja A, Dudeja V.

Gastroenterology. 2018 Sep;155(3):880-891.e8. doi: 10.1053/j.gastro.2018.05.051. Epub 2018 Jul 29.

PMID:
29909021
9.

Grading Using Ki-67 Index and Mitotic Rate Increases the Prognostic Accuracy of Pancreatic Neuroendocrine Tumors.

Philips P, Kooby DA, Maithel S, Merchant NB, Weber SM, Winslow ER, Ahmad S, Kim HJ, Scoggins CR, McMasters KM, Martin RCG 2nd.

Pancreas. 2018 Mar;47(3):326-331. doi: 10.1097/MPA.0000000000000990.

PMID:
29351120
10.

Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth.

Messaggio F, Mendonsa AM, Castellanos J, Nagathihalli NS, Gorden L, Merchant NB, VanSaun MN.

Oncotarget. 2017 Aug 3;8(49):85378-85391. doi: 10.18632/oncotarget.19905. eCollection 2017 Oct 17.

11.

Bedside Rounds Valued But Not Preferred: Perceptions of Internal Medicine Residents and Attending Physicians in a Diverse Academic Training Program.

Merchant NB, Federman DG.

South Med J. 2017 Aug;110(8):531-537. doi: 10.14423/SMJ.0000000000000689.

PMID:
28771651
12.

Are the Current Guidelines for the Surgical Management of Intraductal Papillary Mucinous Neoplasms of the Pancreas Adequate? A Multi-Institutional Study.

Wilson GC, Maithel SK, Bentrem D, Abbott DE, Weber S, Cho C, Martin RC, Scoggins CR, Kim HJ, Merchant NB, Kooby DA, Edwards MJ, Ahmad SA.

J Am Coll Surg. 2017 Apr;224(4):461-469. doi: 10.1016/j.jamcollsurg.2016.12.031. Epub 2017 Jan 11.

PMID:
28088598
13.

Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.

Nagathihalli NS, Castellanos JA, VanSaun MN, Dai X, Ambrose M, Guo Q, Xiong Y, Merchant NB.

Oncotarget. 2016 Oct 4;7(40):65982-65992. doi: 10.18632/oncotarget.11786.

14.

Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms.

Weiss V, Dueber J, Wright JP, Cates J, Revetta F, Parikh AA, Merchant NB, Shi C.

World J Gastrointest Oncol. 2016 Aug 15;8(8):615-22. doi: 10.4251/wjgo.v8.i8.615.

15.

Teaching at the Bedside: Managing Patient and Learner Expectations in Advance.

Merchant NB, Federman DG.

Ann Am Thorac Soc. 2016 Jun;13(6):994. doi: 10.1513/AnnalsATS.201602-140LE. No abstract available.

PMID:
27295167
16.

Perception Is Reality: quality metrics in pancreas surgery - a Central Pancreas Consortium (CPC) analysis of 1399 patients.

Abbott DE, Martin G, Kooby DA, Merchant NB, Squires MH, Maithel SK, Weber SM, Winslow ER, Cho CS, Bentrem DJ, Kim HJ, Scoggins CR, Martin RC, Parikh AA, Hawkins WG, Ahmad SA.

HPB (Oxford). 2016 May;18(5):462-9. doi: 10.1016/j.hpb.2015.11.006. Epub 2016 Mar 2.

17.

Eat When You Can, Sleep When You Can, and Don't Mess with the Pancreas.

Merchant NB.

Surg Oncol Clin N Am. 2016 Apr;25(2):xv-xvi. doi: 10.1016/j.soc.2016.01.001. No abstract available.

PMID:
27013375
18.

Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer.

Helmink BA, Snyder RA, Idrees K, Merchant NB, Parikh AA.

Surg Oncol Clin N Am. 2016 Apr;25(2):287-310. doi: 10.1016/j.soc.2015.11.008. Epub 2016 Feb 17. Review.

PMID:
27013365
19.

Patient-centred bedside rounds-exploring patient preferences before patient-centred care.

Merchant NB, Federman DG.

BMJ Qual Saf. 2016 Feb 29. pii: bmjqs-2016-005372. doi: 10.1136/bmjqs-2016-005372. [Epub ahead of print] No abstract available.

PMID:
26929444
20.

Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response.

Walsh AJ, Castellanos JA, Nagathihalli NS, Merchant NB, Skala MC.

Pancreas. 2016 Jul;45(6):863-9. doi: 10.1097/MPA.0000000000000543.

Supplemental Content

Loading ...
Support Center